Login
$RLAY
$18.84 +$0.72 (3.97%) Close

Company Executives

$RLAY Management Team

Dr. Donald Bergstrom

President - Research and Development

Age 53
Compensation $6.613M USD
Sex Male

Mr. Peter Rahmer

Chief Corporate Development Officer

Age 43
Compensation $4.964M USD
Sex Male

Mr. Brian Adams

Chief Legal Officer

Secretary

Age 51
Compensation $4.365M USD
Sex Male

Mr. Alexis Borisy

Independent Chairman of the Board

Age 53
Compensation $581.1K USD
Sex Male

Dr. Sanjiv Patel

President

Chief Executive Officer

Director

Age 51
Compensation $13.08M USD
Sex Male

Mr. Thomas Catinazzo

Chief Financial Officer

Age 48
Compensation $4.401M USD
Sex Male
Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
5.8 years
from year joined
CEO also chairs the board
No
Alexis Borisy
Director Age On board Independent Committees Other public boards 2025 pay Source
Douglas S. Ingram
63 2019
7 years
Independent None stated Sarepta Therapeutics, Inc., Arrowhead Pharmaceuticals, Inc. $372,999
Claire Mazumdar, Ph.D.
36 2025
1 year
Independent None stated Bicara Therapeutics, Inc. $999,999
Sanjiv K. Patel, M.D.
52 2017
9 years
Not independent None stated None stated Paid as CEO
Linda A. Hill, Ph.D.
69 2018
8 years
Independent None stated None stated $375,499
Lonnel Coats
61 2025
1 year
Independent None stated None stated $985,944
Alexis Borisy
54 2015
11 years
Independent None stated None stated $410,499
Mark Murcko, Ph.D.
66 2016
10 years
Independent None stated None stated $378,923
Habib Joseph Dable
56 2025
1 year
Independent None stated Day One Biopharmaceuticals, Inc., PepGen Inc., SpyGlass Pharma, Inc. $985,156
Sekar Kathiresan, M.D. Leaving at the meeting
54 2022
4 years
Independent None stated None stated $362,999

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support